Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
MEDICAL FRONTIERS - AMMI Canada–CACMID Annual Conference 2022
“Long-COVID is Not New” Long-term Sequelae Common in Flu, Especially in Older Adults, Say Influenza Researchers
Vancouver, BC / April 5-8, 2022
Vancouver – Influenza started to make a comeback worldwide and in Canada towards the end of 2021, emerging from the 2020–2021 pandemic lockdowns. A symposium at the recent AMMI Canada-CACMID annual conference updated...
PRIORITY PRESS - 63rd Annual Meeting of the American Society of Hematology (ASH)
PNH in the Pandemic: New Science and New Treatments in the Spotlight at ASH 2021
In-person/virtual, Atlanta, Georgia / December 11–13, 2021
In-person/Virtual – The 63rd ASH Annual Meeting featured a solid scientific line-up on paroxysmal nocturnal hemoglobinuria (PNH), despite the rarity of the disease, with five events and 23 posters. For Canadian PNH specialists, the...
MEDICAL FRONTIERS - Canadian Immunization Conference (CIC 2021)
“Could Anything Be Worse than COVID?” A Flu Pandemic, Say Influenza Researchers
Online / December 8–9, 2021
Online – While acknowledging that the current focus is on SARS-CoV-2 vaccination, influenza researchers at this year’s Canadian Immunization Conference reminded delegates that, if scaled up to 2021, the 1918–1920 flu...
PRIORITY PRESS - Kidney Week 2021 (American Society of Nephrology)
Rare Kidney Disease in the Time of COVID: Update on Atypical Hemolytic Uremic Syndrome (aHUS)
Online / November 4–7, 2021
Online – Despite its rarity, atypical hemolytic uremic syndrome (aHUS) featured prominently in this year’s virtual Kidney Week – including the second reported case worldwide of aHUS due to COVID-19. Presenters explored the...
PRIORITY PRESS - EHA2021 Virtual – European Hematology Association (EHA)
Hematology in a time of COVID: Update on Paroxysmal Nocturnal Hemoglobinuria (PNH)
Online / June 9–17, 2021
Online – This year’s European Hematology Association meeting (EHA2021) covered the new medical realities of hematology during the COVID-19 pandemic. Expert panels discussed the impact of SARS-CoV-2 on clinical decision-making in...
MEDICAL FRONTIERS - Canadian Immunization Conference (CIC 2020)
Influenza Researchers Explore Real-World Data for Flu-Vaccine Evaluation and Learnings for COVID-19
Online / December 1-3, 2020
Online – Although the COVID-19 pandemic dominates the infectious disease headlines, influenza remains a striking public-health problem in Canada, with up to 7 million people sickened during a non-pandemic flu season. The seasonal...
MEDI-NEWS - Influenza Vaccine Effectiveness in Seniors and Other High-risk Groups
An overview of new data on the relative effectiveness of flu vaccines in vulnerable populations
September 2020
As healthcare professionals prepare for flu season in a pandemic year, the results of three large, population-based U.S. studies now provide comparisons of the relative effectiveness (rVE) of the available flu vaccine formulations in...
MEDI-NEWS Prevention of Japanese Encephalitis in Canadian Travellers
An overview of new guidelines released by the Committee to Advise on Tropical Medicine and Travel (CATMAT) and the Public Health Agency of Canada (PHAC)
December 2019
In December, 2019, CATMAT released a Statement on the Prevention of Japanese Encephalitis1 for Canadian travellers, following a similar endeavour by the US Centers for Disease Control and Prevention (CDC) released in July, 20192. Japanese...
PRIORITY PRESS - 17th Annual Discovery on Target Conference
Leveraging Years of Data on GPCRs for Transformative Drug Discovery
Boston, USA / September 16–19, 2019
Boston - GPCRs, which play a role in most biological processes, remain one of the most vibrant fields for drug discovery and perhaps the single largest source of untapped therapeutic potential. Years of data are increasingly...